Oral creatine supplementation in humans does not elevate urinary excretion of the carcinogen N-nitrososarcosine

Nutrition. 2006 Mar;22(3):332-3. doi: 10.1016/j.nut.2005.10.004. Epub 2006 Jan 18.

Abstract

Objective: Creatine is a popular oral supplement in athletes and may have therapeutical potential in neuromuscular diseases. It has been hypothesized that creatine ingestion can lead to increased formation of the carcinogen N-nitrososarcosine.

Methods: We investigated in a double-blind, placebo-controlled study the urinary excretion of N-nitrososarcosine after 1-wk high-dose (20 g/d) and 20-wk low-dose (5 g/d) creatine supplementation in healthy humans.

Results and conclusion: Creatine ingestion does not systematically increase urinary N-nitrososarcosine excretion.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Carcinogens / metabolism
  • Creatine / administration & dosage*
  • Creatine / adverse effects
  • Creatine / metabolism*
  • Dietary Supplements
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Nitrosamines / urine*

Substances

  • Carcinogens
  • Nitrosamines
  • N-nitrososarcosine
  • Creatine